Login to Your Account



Pluristem, United Therapeutics Sign $62M Licensing Deal

By Mari Serebrov


Tuesday, June 21, 2011
Pluristem Ltd. is getting more fuel for its PLacental eXpanded (PLX) cell pipeline in a $62 million licensing deal with United Therapeutics Corp.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription